DNA testing for live kidney donors at risk for autosomal dominant polycystic kidney disease

Transplantation

Volumn 87, Issue 1, 2009, Pages 133-137

  Huang, Edmund ^a   Samaniego Picota, Millie ^a,b   McCune, Thomas ^c   Melancon, Joseph K ^a   Montgomery, Robert A ^a   Ugarte, Richard ^a   Kraus, Edward ^a   Womer, Karl ^a   Rabb, Hamid ^a   Watnick, Terry ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c SENTARA NORFOLK GENERAL HOSPITAL   (United States)

Author keywords

DNA testing; Genetic screening; Living donation; Molecular diagnostics; Polycystic kidney disease

Indexed keywords

POLYCYSTIN 1; POLYCYSTIN 2; DNA; POLYCYSTIC KIDNEY DISEASE 1 PROTEIN; POLYCYSTIN;

ADULT; ARTICLE; AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE; CONTROLLED STUDY; DNA DETERMINATION; DONOR SELECTION; FEMALE; HUMAN; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; PATIENT SAFETY; PRIORITY JOURNAL; RISK FACTOR; ALGORITHM; DONOR; ECHOGRAPHY; GENETIC SCREENING; GENETICS; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE;

ADULT; ALGORITHMS; BASE SEQUENCE; DNA; GENETIC SCREENING; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; MIDDLE AGED; MUTATION; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; RISK FACTORS; TISSUE DONORS; TRPP CATION CHANNELS;

EID: 58949083551     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318191e729     Document Type: Article

References (18)

1. Gabow PA. Autosomal dominant polycystic kidney disease. N Engl J Med 1993;329:332.
2. Iglesias CG, Torres VE, Offord KP, et al. Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980. Am J Kidney Dis 1983;2:630.
3. Churchill DN, Bear JC, Morgan J, et al. Prognosis of adult onset polycystic kidney disease re-evaluated. Kidney Int 1984;26:190.
4. Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet 2007;369:1287.
5. Rossetti S, Consugar MB, Chapman AB, et al. Comprehensive molecular diagnostics inautosomal dominant polycystic kidney disease. J Am Soc Nephrol 2007;18:2143.
6. Hateboer N, v Dijk MA, Bogdanova N, et al. Comparison of pheno-types ofpolycystic kidney disease types 1 and 2.European PKD1-PKD2 Study Group. Lancet 1999;353:103.
7. RavineD, Gibson RN, Walker RG,et al. Evaluationofultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 1994;343:824.
8. Harris PC, Bae KT, Rossetti S, et al. Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2006;17:3013.
9. Pei Y, Obaji J, Dupuis A, et al. Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol 2008; Oct 22 [Epub ahead of print].
10. Carrim ZI, Murchison JT. The prevalence of simple renal and hepatic cysts detected by spiral computed tomography. Clin Radiol 2003;58:626.
11. Nascimento AB, Mitchell DG, Zhang XM, et al. Rapid MR imaging detection of renal cysts: age-based standards. Radiology 2001;221:628.
12. Burke W. Genetic testing. N Engl J Med 2002;347:1867.
13. Phakdeekitcharoen B, Watnick TJ, Germino GG. Mutation analysis of the entire replicated portion of PKD1 using genomic DNA samples. J Am Soc Nephrol 2001;12:955.
14. Watnick TJ, Piontek KB, Cordal TM, et al. An unusual pattern of mutation in the duplicated portion of PKD1 is revealed by use of a novel strategy for mutation detection. Hum Mol Genet 1997;6:1473.
15. Garcia-Gonzalez MA, Jones JG, Allen SK, et al. Evaluating the clinical utility of a molecular genetic test for polycystic kidney disease. Mol Genet Metab 2007;92:160.
16. Rossetti S, Chauveau D, Walker D, et al. A complete mutation screen of the ADPKD genes by DHPLC. Kidney Int 2002;61:1588.
17. Yen EF, Hardinger K, Brennan DC, et al. Cost-effectiveness of extending Medicare coverageof immunosuppressive medicationstothe life of a kidney transplant. Am J Transplant 2004;4:1703.
18. U.S. Renal Data System, USRDS 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. 2007.